We are excited to announce that the repository will soon undergo an upgrade, featuring a new look and feel along with several enhanced features to improve your experience. Please be on the lookout for further updates and announcements regarding the launch date. We appreciate your support and look forward to unveiling the improved platform soon.
Browsing by UP Author "Du Plessis, Anna M.E."
-
Du Plessis, Anna M.E.
(Medpharm Publications, 2015)
Attention-deficit/hyperactivity disorder is a common neurobehavioural disorder that compromises the core symptoms of
developmentally inappropriate levels of inattention, impulsivity and hyperactivity. Many patients are ...
-
Govender, Catherine; Du Plessis, Anna M.E.; Bipath, Priyesh; Povey, D.; Viviers, G.; Viljoen, Margaretha
(In House Publications, 2010-03)
OBJECTIVE: It is posited that the effect of depression on BMD is dependent on the severity of depression. Conflicting evidence
exists regarding this possible association. This study investigated the association between ...
-
Viljoen, Margaretha; Du Plessis, Anna M.E.; Govender, Catherine; Bipath, Priyesh
(2008-09-29)
The study’s aim was to investigate the association between depression and low bone mineral density (BMD) in premenopausal females. Depression is often characterized by cortisol hypersecretion. Cortisol supports osteoclastogenesis ...
-
Cuchel, Marina; Meagher, Emma A.; Theron, Hendrik Du Toit; Blom, Dirk J.; Marais, A. David; Hegele, Robert A.; Averna, Maurizio R.; Sirtori, Cesare R.; Shah, Prediman K.; Gaudet, Daniel; Stefanutti, Claudia; Vigna, Giovanni B.; Du Plessis, Anna M.E.; Propert, Kathleen J.; Sasiela, William J.; Bloeden, LeAnne T.; Rader, Daniel J.
(Elsevier, 2013)
BACKGROUND Patients with homozygous familial hypercholesterolaemia respond inadequately to existing drugs. We
aimed to assess the effi cacy and safety of the microsomal triglyceride transfer protein inhibitor lomitapide ...
-
Stefanutti, Claudia; Blom, Dirk J.; Averna, Maurizio R.; Meagher, Emma A.; Theron, Hendrik Du Toit; Marais, A. David; Hegele, Robert A.; Sirtori, Cesare R.; Shah, Prediman K.; Gaudet, Daniel; Vigna, Giovanni B.; Sachais, B.S.; Di Giacomo, S.; Du Plessis, Anna M.E.; Bloeden, LeAnne T.; Balser, J.; Rader, Daniel J.; Cuchel, Marina
(Elsevier, 2015-06)
OBJECTIVE : Lomitapide (a microsomal triglyceride transfer protein inhibitor) is an adjunctive treatment
for homozygous familial hypercholesterolaemia (HoFH), a rare genetic condition characterised by
elevated low-density ...
